Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 11Neoplasms 5Parasomnias 4Depression 3Weight Loss 2Tuberous Sclerosis 2Smith-Magenis Syndrome 2Sleep Wake Disorders 2Polycystic Ovary Syndrome 2Pain 2Lung Neoplasms 2Fatigue 2Cachexia 2Autism Spectrum Disorder 2Anxiety Disorders 2Angelman Syndrome 2Uveal Melanoma 1Squamous Cell Carcinoma of Head and Neck 1Sleep Disorders, Circadian Rhythm 1Relapsed Malignant Solid Tumor 1Radiodermatitis 1Radiation Injuries 1Quality of Life 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Neoplasm Metastasis 1Melanoma 1Leukoplakia, Oral 1Keratosis, Actinic 1Hematologic Neoplasms 1Head and Neck Neoplasms 1

Interventions

Dexmedetomidine 5Saline Solution 4Haloperidol 4Sodium Chloride 3Propofol 2Lorazepam 2suvorexant 1remimazolam 1haloperidol decanoate 1flurbiprofen axetil 1dexamethasone 21-phosphate 1Vitamin E 1Surveys and Questionnaires 1Standard of Care 1Sevoflurane 1Practice Guidelines as Topic 1Olanzapine 1Midazolam 1Melatonin 1Interviews as Topic 1Injections 1Inhalation 1Ibuprofen 1Donepezil 1Dexamethasone 1Chlorpromazine 1Anesthesia, Spinal 1Acetaminophen 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Delirium × Melatonin × Clear all
NCT02200172 2016-07-19

The Preventative Role of Exogenous Melatonin Administration in Patients With Advanced Cancer Who Are at Risk of Delirium: a Feasibility Study

Bruyère Health Research Institute.

Phase 2 Completed
60 enrolled

Delirium, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡